Zusammenfassung
Die diabetische Ketoazidose (DKA) und der hyperosmolare hyperglykämische Status (HHS) sind lebensbedrohliche akute Komplikationen eines Diabetes mellitus. Die Behandlung sollte außer bei milden Fällen auf einer internistischen Intensivstation erfolgen. Klinisch unterscheidet sich die DKA vom HHS durch das Vorliegen einer metabolischen Azidose. Trotz dieses Unterschieds ist die Therapie der DKA und des HHS prinzipiell gleich. Sie besteht aus der intravenösen Gabe von Insulin und der Korrektur der Hypovolämie, sowie der Elektrolytveränderungen. Durch die Anwendung eines standardisierten Behandlungsprotokolls kann eine niedrige Sterblichkeit erreicht werden.
Abstract
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are the two most acute life-threatening complications of diabetes mellitus and in most cases treatment should be administered in an intensive care unit. Clinically, DKA and HHS differ according to the presence of metabolic acidosis; however, the treatment of DKA and HHS is similar. The main principles are intravenous administration of insulin and correction of fluid and electrolyte abnormalities which are typically present. By the application of a standardized treatment algorithm a low mortality rate can be achieved.
Literatur
Thomas T, Köppen S, Hensen, J (2007) Coma diabeticum: aktuelle therapie der diabetischen Ketoazidose und des nicht-ketoazidotischen hyperosmolaren Komas. Diabetologie 2:108
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32:1335
Arieff AI, Carroll HJ (1972) Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases. Medicine (Baltimore) 51(2):73–94
Kitabchi AE, Umpierrez GE, Fisher JN et al (2008) Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab 93:1541
Böhm BO, Dreyer M, Firtsche A et al (2011–2013) Evidenzbasierte Leitlinie zur Therapie des Typ 1 Diabetes der Deutschen Diabetes Gesellschaft. http://www.deutsche-diabetes-gesellschaft.de/leitlinien/evidenzbasierte leitlinien.html
Kitabchi AE, Umpierrez GE, Murphy MB et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131
Middleton P, Kelly AM, Brown J, Robertson M (2006) Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate. Emerg Med J 23:622
Hillman K (1987) Fluid resuscitation in diabetic emergencies—a reappraisal. Intensive Care Med 13:4
Waldhäusl W, Kleinberger G, Korn A et al (1979) Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 28:577
Hillier TA, Abbott RD, Barrett EJ (1999) Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 106:399
Viallon A, Zeni F, Lafond P et al (1999) Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med 27:2690
Morris LR, Murphy MB, Kitabchi AE (1986) Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 105:836
Lever E, Jaspan JB (1983) Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med 75:263
Latif KA, Freire AX, Kitabchi AE et al (2002) The use of alkali therapy in severe diabetic ketoacidosis. Diabetes Care 25:2113
Narins RG, Cohen JJ (1987) Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med 106:615
Okuda Y, Adrogue HJ, Field JB et al (1996) Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab 81:314
Fisher JN, Kitabchi AE (1983) A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57:177
Keller U, Berger W (1980) Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes 29:87
Wilson HK, Keuer SP, Lea AS et al (1982) Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 142:517
Barsotti MM (1980) Potassium phosphate and potassium chloride in the treatment of DKA. Diabetes Care 3:569
Winter RJ, Harris CJ, Phillips LS, Green OC (1979) Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 67:897
Zipf WB, Bacon GE, Spencer ML et al (1979) Hypocalcemia, hypomagnesemia, and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diabetes Care 2:265
Kreisberg RA (1977) Phosphorus deficiency and hypophosphatemia. Hosp Pract 12:121
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schneider, S. Hyperglykämische Krise bei Patienten mit Diabetes mellitus. Med Klin Intensivmed Notfmed 107, 435–439 (2012). https://doi.org/10.1007/s00063-012-0114-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-012-0114-1
Schlüsselwörter
- Diabetes mellitus
- Hyperglykämische Krise
- Diabetische Ketoazidose
- Hyperosmolarer hyperglykämischer Status
- Intensivstation